Nebunie (Romanian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nebunie" in Romanian language version.

refsWebsite

Global rank Romanian rank

9nih.gov

4^th place

8doi.org

2^nd place

3^rd place

3nice.org.uk

3,258^th place

1,726^th place

2google.ca

838^th place

285^th place

2web.archive.org

1^st place

1who.int

195^th place

100^th place

1fda.gov

447^th place

173^rd place

doi.org

Burns, A; Iliffe, S (5 februarie 2009). „Dementia”. BMJ (Clinical research ed.). 338: b75. doi:10.1136/bmj.b75. PMID 19196746.
Loy, CT; Schofield, PR; Turner, AM; Kwok, JB (1 martie 2014). „Genetics of dementia”. Lancet. 383 (9919): 828–40. doi:10.1016/s0140-6736(13)60630-3. PMID 23927914.
Birks, J (25 ianuarie 2006). „Cholinesterase inhibitors for Alzheimer's disease”. The Cochrane database of systematic reviews (1): CD005593. doi:10.1002/14651858.CD005593. PMID 16437532.
Rolinski, M; Fox, C; Maidment, I; McShane, R (14 martie 2012). „Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease”. The Cochrane database of systematic reviews. 3: CD006504. doi:10.1002/14651858.CD006504.pub2. PMID 22419314.
Kavirajan, H; Schneider, LS (septembrie 2007). „Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials”. The Lancet. Neurology. 6 (9): 782–92. doi:10.1016/s1474-4422(07)70195-3. PMID 17689146.
Forbes, D.; Thiessen, E.J.; Blake, C.M.; Forbes, S.C.; Forbes, S. (4 decembrie 2013). „Exercise programs for people with dementia”. The Cochrane database of systematic reviews. 12: CD006489. doi:10.1002/14651858.CD006489.pub3. PMID 24302466.
Larson, EB; Yaffe, K; Langa, KM (12 decembrie 2013). „New insights into the dementia epidemic”. The New England Journal of Medicine. 369 (24): 2275–7. doi:10.1056/nejmp1311405. PMID 24283198.
GBD 2013 Mortality and Causes of Death, Collaborators (17 decembrie 2014). „Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013”. Lancet. 385 (9963): 117–71. doi:10.1016/S0140-6736(14)61682-2. PMID 25530442.

fda.gov

„Information for Healthcare Professionals: Conventional Antipsychotics”. fda.gov. June 16 2008. Accesat în 29 noiembrie 2014. Verificați datele pentru: |date= (ajutor)

google.ca

books.google.ca

Gauthier, Serge (2006). Clinical diagnosis and management of Alzheimer's disease (ed. 3rd ed.). Abingdon, Oxon: Informa Healthcare. pp. 53–54. ISBN 9780203931714. Mentenanță CS1: Text în plus (link)
Umphred, Darcy (2012). Neurological rehabilitation (ed. 6th ed.). St. Louis, Mo.: Elsevier Mosby. p. 838. ISBN 9780323075862. Mentenanță CS1: Text în plus (link)

nice.org.uk

pathways.nice.org.uk

„Dementia diagnosis and assessment” (PDF). pathways.nice.org.uk. Arhivat din original (PDF) la 5 decembrie 2014. Accesat în 30 noiembrie 2014.
„Dementia overview” (PDF). http://pathways.nice.org.uk/. Arhivat din original (PDF) la 5 decembrie 2014. Accesat în 30 noiembrie 2014. Legătură externa în |website= (ajutor)

nice.org.uk

National Institute for Health and Clinical Excellence. „Low-dose antipsychotics in people with dementia”. nice.org.uk. Accesat în 29 noiembrie 2014.

nih.gov

ncbi.nlm.nih.gov

Burns, A; Iliffe, S (5 februarie 2009). „Dementia”. BMJ (Clinical research ed.). 338: b75. doi:10.1136/bmj.b75. PMID 19196746.
Loy, CT; Schofield, PR; Turner, AM; Kwok, JB (1 martie 2014). „Genetics of dementia”. Lancet. 383 (9919): 828–40. doi:10.1016/s0140-6736(13)60630-3. PMID 23927914.
Birks, J (25 ianuarie 2006). „Cholinesterase inhibitors for Alzheimer's disease”. The Cochrane database of systematic reviews (1): CD005593. doi:10.1002/14651858.CD005593. PMID 16437532.
Rolinski, M; Fox, C; Maidment, I; McShane, R (14 martie 2012). „Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease”. The Cochrane database of systematic reviews. 3: CD006504. doi:10.1002/14651858.CD006504.pub2. PMID 22419314.
Kavirajan, H; Schneider, LS (septembrie 2007). „Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials”. The Lancet. Neurology. 6 (9): 782–92. doi:10.1016/s1474-4422(07)70195-3. PMID 17689146.
Commission de la transparence (iunie 2012). „Médicaments de la maladie d'Alzheimer : à éviter” [Drugs for Alzheimer's disease: best avoided. No therapeutic advantage]. Prescrire Int. 21 (128): 150. PMID 22822592.
Forbes, D.; Thiessen, E.J.; Blake, C.M.; Forbes, S.C.; Forbes, S. (4 decembrie 2013). „Exercise programs for people with dementia”. The Cochrane database of systematic reviews. 12: CD006489. doi:10.1002/14651858.CD006489.pub3. PMID 24302466.
Larson, EB; Yaffe, K; Langa, KM (12 decembrie 2013). „New insights into the dementia epidemic”. The New England Journal of Medicine. 369 (24): 2275–7. doi:10.1056/nejmp1311405. PMID 24283198.
GBD 2013 Mortality and Causes of Death, Collaborators (17 decembrie 2014). „Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013”. Lancet. 385 (9963): 117–71. doi:10.1016/S0140-6736(14)61682-2. PMID 25530442.

web.archive.org

„Dementia diagnosis and assessment” (PDF). pathways.nice.org.uk. Arhivat din original (PDF) la 5 decembrie 2014. Accesat în 30 noiembrie 2014.
„Dementia overview” (PDF). http://pathways.nice.org.uk/. Arhivat din original (PDF) la 5 decembrie 2014. Accesat în 30 noiembrie 2014. Legătură externa în |website= (ajutor)

who.int

„Dementia Fact sheet N°362”. who.int. aprilie 2012. Accesat în 28 noiembrie 2014.